Literature DB >> 32730772

Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections.

J Y Tan1, E P Conceicao2, X Y J Sim3, L E I Wee4, M K Aung2, I Venkatachalam3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32730772      PMCID: PMC7384982          DOI: 10.1016/j.jhin.2020.07.023

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


× No keyword cloud information.
Sir, During the coronavirus disease 2019 (COVID-19) pandemic, Singapore implemented various measures to mitigate the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These included border controls, social distancing, community education, lockdown, and compulsory wearing of masks in public. We report that public health measures not only reduced SARS-CoV-2 transmission but that they also reduced transmission of endemic community respiratory viral infections. The number of hospital admissions for respiratory viral infections since the beginning of the COVID-19 outbreak was compared with that of the preceding three years at Singapore General Hospital. All laboratory confirmed community onset (defined as a positive respiratory viral swab within 72 h of admission) respiratory viruses that were admitted to our hospital from January 1st, 2017 to July 1st, 2020 were studied. Patients with respiratory viral infections were confirmed using a 16-target respiratory viral polymerase chain reaction assay (respiratory syncytial virus A/B, influenza A/B, parainfluenza viruses 1–4, metapneumovirus, rhinovirus A/B/C, human coronavirus OC43/229E/NL63, adenovirus, human enterovirus, human bocavirus 1–4) on oropharyngeal specimens. A significant decrease in hospital admissions was observed for both non-influenza respiratory viruses and influenza (Figure 1 ) from EW 7 onwards. Epidemiological weekly (EW) positive rates (positive swabs divided by total number of swabs) were compared. For non-influenza respiratory virus, the mean (± standard deviation) weekly positive rate from 2017 EW 1 to 2019 EW 52 was 16.2 ± 3.9%. Comparatively, the mean weekly positive rate was 50% lower during EW 7–14, 2020 (8.2 ± 2.9%, P < 0.001), and 80% lower during EW 15–27, 2020 (3.2 ± 2.0%, P < 0.001). Influenza cases were also significantly lower. Mean weekly positive rates during EW 7–14, 2020, were 75–80% lower when compared individually to the same period in the preceding three years (1.4 ± 1.1% vs 8.4 ± 3.2% in 2017, 8.1 ± 3.1% in 2018, and 5.6 ± 2.7% in 2019; P < 0.001). During the influenza season, instead of the usual rise in admissions, our hospital experienced a decrease of >90% when again compared to the same period (EW 15–27) in the preceding three years (0.6 ± 0.4% vs 18.6 ± 6.6% in 2017, 7.5 ± 3.1% in 2018, and 8.1 ± 5.0% in 2019; P < 0.001). Consequently, the number of intensive care unit admissions for respiratory viruses also decreased.
Figure 1

(A) Non-influenza respiratory virus cases and number of swabs done. (B) Influenza cases and number of swabs done.

(A) Non-influenza respiratory virus cases and number of swabs done. (B) Influenza cases and number of swabs done. The implementation of public health measures to curb COVID-19 transmission had an unintended but beneficial consequence of reducing respiratory viral infection hospital admissions. Two other studies in Singapore had reported reduction in influenza cases as a consequence of COVID-19 public health measures, but both studies ended before the influenza season [1,2]. Our study reported the lowest rates in the past three years, even during the influenza season, strongly supporting the effectiveness of public health measures. This is consistent with national data which also reported the lowest ever influenza incidence in the community from EW 14 to EW 23 [3]. We demonstrated the chronological implementation of public health measures to match these measures with the decrease in weekly respiratory virus hospital admissions and we evaluated their individual effectiveness. The Global Influenza Programme had reported the effectiveness of various non-pharmaceutical measures to prevent influenza transmission [4]. In Singapore, the combination of public health measures effectively reduced community respiratory virus admissions. Unfortunately, it is difficult to accurately assess the effectiveness of each individual public health measure. Each sequential measure additively contributed to the reduction in respiratory viral admissions to our hospital. Our findings suggest that measures such as social distancing and public hygiene are indeed effective in reducing respiratory viral transmission, as demonstrated by the decrease in cases after EW 7. The lockdown helped to further halt transmission and reduce hospital admissions, though this would not be a feasible measure in the long run. The compulsory wearing of masks was implemented during the lockdown period (EW 15 onwards), and makes it difficult to assess the effectiveness of this measure alone in reducing transmission rates. However, when Singapore entered phase 2 of re-opening on June 19th (EW 25) and allowed social gatherings limited to five people while continuing to emphasize compulsory wearing of masks in public, the number of admissions remained low. As Singapore continues to re-open, allowing larger social gatherings, future studies will potentially be able to evaluate the true effectiveness of wearing face masks, as this measure is likely to continue. Respiratory viruses will continue to circulate in the community and cause significant morbidity in at-risk populations [5]. Social distancing, though effective, may not be sustainable as a long-term measure. Face masks, however, though of debateable effectiveness, are a simple and practical measure and can potentially help to reduce transmission rates. This has potential impact on current and future public health recommendations, especially for vulnerable groups such as the elderly, patients with chronic lung diseases, and the immunocompromised, who may suffer severe consequences from a run-of-the-mill respiratory viral infection.
  16 in total

1.  Out-of-Season Epidemic of Respiratory Syncytial Virus during the COVID-19 Pandemic: The High Burden of Child Hospitalization in an Academic Hospital in Southern Italy in 2021.

Authors:  Daniela Loconsole; Francesca Centrone; Caterina Rizzo; Désirée Caselli; Azzurra Orlandi; Fabio Cardinale; Cristina Serio; Paola Giordano; Giuseppe Lassandro; Leonardo Milella; Maria Teresa Ficarella; Maria Elisabetta Baldassarre; Nicola Laforgia; Maria Chironna
Journal:  Children (Basel)       Date:  2022-06-08

Review 2.  One Year on: An Overview of Singapore's Response to COVID-19-What We Did, How We Fared, How We Can Move Forward.

Authors:  S Vivek Anand; Yao Kang Shuy; Poay Sian Sabrina Lee; Eng Sing Lee
Journal:  Int J Environ Res Public Health       Date:  2021-08-30       Impact factor: 4.614

3.  Impact of the influenza vaccine on COVID-19 infection rates and severity.

Authors:  Anna Conlon; Carmel Ashur; Laraine Washer; Kim A Eagle; Marion A Hofmann Bowman
Journal:  Am J Infect Control       Date:  2021-02-22       Impact factor: 2.918

4.  Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study.

Authors:  Kyungmin Huh; Young-Eun Kim; Wonjun Ji; Dong Wook Kim; Eun-Joo Lee; Jong-Hun Kim; Ji-Man Kang; Jaehun Jung
Journal:  Thorax       Date:  2021-03-29       Impact factor: 9.139

5.  COVID-19 pandemic and its consequences disrupt epidemiology of enterovirus meningitis, South-East France.

Authors:  Léa Luciani; Laetitia Ninove; Christine Zandotti; Antoine Nougairède
Journal:  J Med Virol       Date:  2021-01-22       Impact factor: 2.327

6.  Reduction in Hospitalizations for Respiratory Diseases during the First COVID-19 Wave in Greece.

Authors:  Christos Kyriakopoulos; Athena Gogali; Konstantinos Exarchos; Dimitrios Potonos; Konstantinos Tatsis; Vasiliki Apollonatou; Stelios Loukides; Spyros Papiris; Ioanna Sigala; Paraskevi Katsaounou; Maximos Aggelidis; Evangelika Fouka; Konstantinos Porpodis; Theodoros Kontakiotis; Fotis Sampsonas; Theodoros Karampitsakos; Argyris Tzouvelekis; Eleni Bibaki; Konstantinos Karagiannis; Katerina Antoniou; Nikolaos Tzanakis; Ilias Dimeas; Zoe Daniil; Konstantinos Gourgoulianis; Maria Kouratzi; Paschalis Steiropoulos; Emmanouil Antonakis; Ilias C Papanikolaou; Georgios Ntritsos; Konstantinos Kostikas
Journal:  Respiration       Date:  2021-04-07       Impact factor: 3.580

7.  Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.

Authors:  Angela B Brueggemann; Melissa J Jansen van Rensburg; David Shaw; Noel D McCarthy; Keith A Jolley; Martin C J Maiden; Mark P G van der Linden; Zahin Amin-Chowdhury; Désirée E Bennett; Ray Borrow; Maria-Cristina C Brandileone; Karen Broughton; Ruth Campbell; Bin Cao; Carlo Casanova; Eun Hwa Choi; Yiu Wai Chu; Stephen A Clark; Heike Claus; Juliana Coelho; Mary Corcoran; Simon Cottrell; Robert J Cunney; Tine Dalby; Heather Davies; Linda de Gouveia; Ala-Eddine Deghmane; Walter Demczuk; Stefanie Desmet; Richard J Drew; Mignon du Plessis; Helga Erlendsdottir; Norman K Fry; Kurt Fuursted; Steve J Gray; Birgitta Henriques-Normark; Thomas Hale; Markus Hilty; Steen Hoffmann; Hilary Humphreys; Margaret Ip; Susanne Jacobsson; Jillian Johnston; Jana Kozakova; Karl G Kristinsson; Pavla Krizova; Alicja Kuch; Shamez N Ladhani; Thiên-Trí Lâm; Vera Lebedova; Laura Lindholm; David J Litt; Irene Martin; Delphine Martiny; Wesley Mattheus; Martha McElligott; Mary Meehan; Susan Meiring; Paula Mölling; Eva Morfeldt; Julie Morgan; Robert M Mulhall; Carmen Muñoz-Almagro; David R Murdoch; Joy Murphy; Martin Musilek; Alexandre Mzabi; Amaresh Perez-Argüello; Monique Perrin; Malorie Perry; Alba Redin; Richard Roberts; Maria Roberts; Assaf Rokney; Merav Ron; Kevin J Scott; Carmen L Sheppard; Lotta Siira; Anna Skoczyńska; Monica Sloan; Hans-Christian Slotved; Andrew J Smith; Joon Young Song; Muhamed-Kheir Taha; Maija Toropainen; Dominic Tsang; Anni Vainio; Nina M van Sorge; Emmanuelle Varon; Jiri Vlach; Ulrich Vogel; Sandra Vohrnova; Anne von Gottberg; Rosemeire C Zanella; Fei Zhou
Journal:  Lancet Digit Health       Date:  2021-06

Review 8.  Effects of COVID-19 prevention procedures on other common infections: a systematic review.

Authors:  Omid Dadras; Seyed Ahmad Seyed Alinaghi; Amirali Karimi; Mehrzad MohsseniPour; Alireza Barzegary; Farzin Vahedi; Zahra Pashaei; Pegah Mirzapour; Amirata Fakhfouri; Ghazal Zargari; Solmaz Saeidi; Hengameh Mojdeganlou; Hajar Badri; Kowsar Qaderi; Farzane Behnezhad; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-07-03       Impact factor: 2.175

9.  Addressing Stroke Admissions During COVID-19 Pandemic Beyond Fear and Constraining Health Factors.

Authors:  Hipólito Nzwalo; Nicola Logallo
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-02-26       Impact factor: 2.136

10.  Coping with the third wave of the COVID-19 pandemic in Africa: implications for an improved outbreak response.

Authors:  Olayinka Stephen Ilesanmi; Francesco Chirico; Aanuoluwapo Adeyimika Afolabi; Gabriella Nucera
Journal:  Future Virol       Date:  2021-01-17       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.